MOH — authorised 29 July 1981
- Status: likely_approved
MOH authorised Lymphazurin on 29 July 1981
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 29 July 1981.
Marketing authorisation holder not available in our data.